Dr Reddy's Laboratories Net Profit Margin 2010-2025 | RDY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Dr Reddy's Laboratories average net profit margin for 2024 was 18.52%, a 0.75% decline from 2023.
Dr Reddy's Laboratories average net profit margin for 2023 was 18.66%, a 39.57% decline from 2022.
Dr Reddy's Laboratories average net profit margin for 2022 was 13.37%, a 33.03% increase from 2021.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Dr Reddy's Laboratories average net profit margin for 2024 was 18.52%, a 0.75% decline from 2023.
Dr Reddy's Laboratories average net profit margin for 2023 was 18.66%, a 39.57% decline from 2022.
Dr Reddy's Laboratories average net profit margin for 2022 was 13.37%, a 33.03% increase from 2021.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19B
BridgeBio Pharma (BBIO)	$8.8B
Bausch Health Cos (BHC)	$2.4B
Supernus Pharmaceuticals (SUPN)	$1.9B
Amphastar Pharmaceuticals (AMPH)	$1B
Personalis (PSNL)	$611M
Taysha Gene Therapies (TSHA)	$547M
Assembly Biosciences (ASMB)	$139M
Sol-Gel Technologies (SLGL)	$23M
Evoke Pharma (EVOK)	$9M
Teligent (TLGT)	$0M